BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 12972705)

  • 21. A practical approach to accurate classification and staging of mycosis fungoides and Sézary syndrome.
    Thomas BR; Whittaker S
    Skin Therapy Lett; 2012 Dec; 17(10):5-9. PubMed ID: 23223768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous T-cell lymphoma].
    Dippel E; Gellrich S; Klemke CD; Goerdt S; Sterry W
    J Dtsch Dermatol Ges; 2003 Dec; 1(12):965-80; quiz 981-2. PubMed ID: 16285650
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cutaneous lymphomas].
    Schad K; Baumann Conzett K; Cozzio A
    Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bridging the specialty gap: Update on primary cutaneous lymphomas.
    Olsen EA; Hodak E; Geskin L; Scarisbrick J;
    J Am Acad Dermatol; 2024 Feb; 90(2):257-260. PubMed ID: 38043039
    [No Abstract]   [Full Text] [Related]  

  • 25. Sézary syndrome.
    Davis MD; Alonsollamazares J; McEvoy MT
    Eur J Dermatol; 2007; 17(1):96. PubMed ID: 17324842
    [No Abstract]   [Full Text] [Related]  

  • 26. [Alpha interferon in the therapy of cutaneous T cell lymphomas].
    Lang MH; Altmeyer P; Lodemann E; Holzmann H
    Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario.
    Sanches JA; Cury-Martins J; Abreu RM; Miyashiro D; Pereira J
    An Bras Dermatol; 2021; 96(4):458-471. PubMed ID: 34053802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment.
    Hoppe RT; Wood GS; Abel EA
    Curr Probl Cancer; 1990; 14(6):293-371. PubMed ID: 2245651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are we there yet? cellular therapies for cutaneous T cell lymphoma.
    Atilla PA; Atilla E
    Curr Res Transl Med; 2023; 71(2):103390. PubMed ID: 37062252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous T-cell lymphomas: 2023 update on diagnosis, risk-stratification, and management.
    Hristov AC; Tejasvi T; Wilcox RA
    Am J Hematol; 2023 Jan; 98(1):193-209. PubMed ID: 36226409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous lymphomas: exploration of 10-year data from supraregional mutlidisciplinary team meetings in Glasgow, UK.
    McCusker S; Ngu I
    Clin Exp Dermatol; 2023 Aug; 48(9):1036-1039. PubMed ID: 37140442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.
    Wilcox RA
    Am J Hematol; 2011 Nov; 86(11):928-48. PubMed ID: 21990092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Malignant lymphoma of the skin].
    Burg G; Dommann S; Dummer R
    Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2017.
    Trautinger F; Eder J; Assaf C; Bagot M; Cozzio A; Dummer R; Gniadecki R; Klemke CD; Ortiz-Romero PL; Papadavid E; Pimpinelli N; Quaglino P; Ranki A; Scarisbrick J; Stadler R; Väkevä L; Vermeer MH; Whittaker S; Willemze R; Knobler R
    Eur J Cancer; 2017 May; 77():57-74. PubMed ID: 28365528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous T-cell lymphoma: overview and nursing perspectives.
    McCann SA
    Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary Syndrome.
    Photiou L; van der Weyden C; McCormack C; Miles Prince H
    Curr Oncol Rep; 2018 Mar; 20(4):32. PubMed ID: 29572582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part II: Prognosis and management.
    Oh Y; Stoll JR; Moskowitz A; Pulitzer M; Horwitz S; Myskowski P; Noor SJ
    J Am Acad Dermatol; 2021 Nov; 85(5):1093-1106. PubMed ID: 33945836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new nail in the CTCL coffin.
    Lessin SR
    J Invest Dermatol; 2006 Nov; 126(11):2368-9. PubMed ID: 17041618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
    Sethi TK; Montanari F; Foss F; Reddy N
    Br J Haematol; 2021 Nov; 195(3):352-364. PubMed ID: 33987825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.